Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Patients and data tracking

- PMLiVE

Oncology eBook: Reducing the care gap in cancer prevention, diagnosis, and treatment

Despite significant innovation in the oncology landscape, there is a growing care gap preventing patients accessing and benefiting from innovations in cancer treatment. In this new publication, our oncology experts...

Avalere Health

- PMLiVE

Sanofi’s frexalimab shows promise in relapsing forms of MS

The neurological disease affects approximately 2.8 million people worldwide

- PMLiVE

Listening to patients when they have something to say, not just when we want an answer

By Harry Yeates

- PMLiVE

Amgen reports positive results for inflammatory disease drug Otezla in psoriatic arthritis

The inflammatory condition is estimated to affect nearly 38 million people worldwide

- PMLiVE

UK life sciences sector to receive £650m in government funding

The package includes £121m to speed up clinical trials and improve access to data

EU flag

EMA recommends revoking marketing authorisation for Novartis’ sickle cell disease drug

The EU regulator concluded that the benefits of Adakveo did not outweigh its risks

- PMLiVE

How an AI algorithm might save your life

By Alix Critchley

- PMLiVE

Medscape Medical Affairs Selected as Finalist for 2023 Communiqué Awards

We’re delighted to announce that two Medscape Medical Affairs programs have been selected across different categories as finalists for the 2023 Communiqué Awards. The two programs selected were designed to...

Medscape Medical Affairs

- PMLiVE

COVID-19: Pfizer’s Paxlovid approved by FDA and Gilead’s Veklury recommended by CHMP

Pfizer’s oral antiviral was granted accelerated approval in the US in December 2021

- PMLiVE

BMS and Janssen’s antithrombotic granted FDA fast track designation

The three indications include ischaemic stroke, acute coronary syndrome and atrial fibrillation

- PMLiVE

Gene therapy, gene editing and perspectives on future use in Parkinson’s disease

By Alice Waterhouse

Patient Clinical Trial & Communications Plan Review: A Customer Story

Our client reached out to Impetus to help establish a virtual patient panel with the aim to gather insights on their unmet needs, the most important attributes of treatment, and the impact of...

Impetus Digital

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links